BioMarin Pharmaceutical inventory: A frontrunner in uncommon illness innovation (NASDAQ:BMRN)

hapabapa/iStock Editorial through Getty Photographs BioMarin Pharmaceutical (Nasdaq: BMRN) is among the leaders within the improvement of modern remedies for folks with uncommon and ultra-rare ailments. The corporate’s product portfolio consists of a number of medication similar to Palynziq, Brineura, Voxzogo, and Naglazyme, with gross sales of tons of of tens of millions of {dollars}. … Read more